Zaragoza, Spain

Santiago Ramón García

This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Santiago Ramón García. Retrieved from https://idiyas.com/inventor/santiago-ramón-garcía

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Santiago Ramón García: Innovator in Mycobacterial Infection Treatment

Introduction

Santiago Ramón García is a notable inventor based in Zaragoza, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mycobacterial infections. His innovative work has the potential to impact the lives of many suffering from diseases such as tuberculosis.

Latest Patents

Santiago Ramón García holds a patent for "Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection." This invention relates to a pharmaceutically acceptable salt or ester prodrug for the treatment of mycobacterial infections or diseases resulting from such infections. His patent addresses a critical need in the medical community for effective treatments against tuberculosis.

Career Highlights

Santiago is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the fight against infectious diseases.

Collaborations

He has collaborated with notable colleagues, including Alfonso Mendoza Losana and Ruben Gonzalez Del Rio. These partnerships have fostered a collaborative environment that enhances the development of new treatments.

Conclusion

Santiago Ramón García's contributions to the field of mycobacterial infection treatment exemplify the importance of innovation in healthcare. His work not only advances medical science but also offers hope to those affected by serious infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…